Skip to main content
OSUR
NASDAQ Industrial Applications And Services

Activist Altai Capital Launches Proxy Fight, Demands Strategic Review & Board Seats at OraSure

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Neutral
Importance info
9
Price
$2.98
Mkt Cap
$205.996M
52W Low
$2.08
52W High
$4.22
52W Position info
43% above low
Off High info
29% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

OSUR sits 43% above its 52-week low of $2.08.

Summary

Activist shareholder Altai Capital Management, holding a 5% stake, has launched a proxy contest, publicly detailing its "five-pillar case for change" and demanding board representation to initiate a strategic review, including a potential sale of the company.


Key Events · Corporate Governance and Compliance · OSUR

  • Activist Proxy Contest Launched

    Altai Capital Management, a 5% shareholder, publicly launched a proxy contest, detailing its "five-pillar case for change" and demanding board seats for its nominees, Rishi Bajaj and John Bertrand.

  • Call for Strategic Review and Potential Sale

    Altai Capital is pushing for a comprehensive strategic review, including evaluating a sale of the entire business, which they estimate could yield $4.54 to $6.60 per share, representing a 42% to 107% premium to the current stock price.

  • Criticism of Underperformance and Governance

    The activist highlighted OraSure's chronic stock underperformance, the board's low share ownership, and CEO compensation not tied to share price, especially following significant financial losses reported in the recent 10-K.

  • Board Resignations Noted

    The filing notes the resignation of Mara Aspinall from the board in October 2025, after Altai's discussions made clear they would seek her replacement.


Analysis · OSUR · Industrial Applications And Services

This DFAN14A filing signals a significant escalation in the activist campaign by Altai Capital, one of OraSure's largest shareholders. The detailed letter outlines severe criticisms of OraSure's chronic underperformance, board oversight, and CEO compensation, particularly in light of recent substantial financial losses reported in the 10-K on March 9, 2026. Altai's call for a strategic review, including a potential sale of the entire business at a significant premium to the current share price, presents a major catalyst for the stock. The ongoing public dispute, evidenced by the company's defensive statement on the same day, indicates a contentious battle for control and strategic direction. Investors should closely monitor developments in this proxy contest, as the outcome could lead to fundamental changes in OraSure's operations or ownership structure.

At the time of this filing, OSUR was trading at $2.98 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $206M. The 52-week trading range was $2.08 to $4.22. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

OSUR - Latest Insights

OSUR
Jul 21, 2026, 4:30 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.93
Real-time Price: $3.97 info
Change: +$0.040 (+1%) info
Market Cap: $273.329M info
OSUR
Jun 11, 2026, 9:02 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.11
Real-time Price: $3.97 info
Change: -$0.140 (-3%) info
Market Cap: $273.329M info
OSUR
Jun 11, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $4.15
Real-time Price: $3.97 info
Change: -$0.180 (-4%) info
Market Cap: $273.329M info
OSUR
Jun 03, 2026, 4:32 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.95
Real-time Price: $3.97 info
Change: +$0.020 (+0.51%) info
Market Cap: $273.329M info
OSUR
May 08, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.06
Real-time Price: $3.97 info
Change: +$0.910 (+30%) info
Market Cap: $273.329M info